医药中间体
Etrasimod is a selective sphingosine-1-phosphate (S1P) receptor modulator used as an active pharmaceutical ingredient. It is taken orally and functions by modifying immune system activity, primarily for the management of ulcerative colitis.
内容范围: 本页信息面向化学品识别与工业供应、研发、生产场景，不构成疗效宣称、医疗建议或药品使用指导。
Etrasimod(CAS 1206123-37-6)的国际 HS 编码为 2933.99。
2933.99
2933 99 80
归类依据欧盟海关化学品目录 ECICS(2026-07 快照,HS 2022 版)。各国税则细目及产品形态可能影响最终归类。
2-[(3R)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid
MVGWUTBTXDYMND-QGZVFWFLSA-N
C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CC[C@@H]5CC(=O)O)C(F)(F)F